- Home
- RVPH vs PED Comparison
RVPH vs PED Comparison
Compare RVPH & PED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- PED
- Stock Information
- Founded
- RVPH 2006
- PED N/A
- Country
- RVPH United States
- PED United States
- Employees
- RVPH N/A
- PED N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- PED Oil & Gas Production
- Sector
- RVPH Health Care
- PED Energy
- Exchange
- RVPH Nasdaq
- PED Nasdaq
- Market Cap
- RVPH 87.6M
- PED 77.0M
- IPO Year
- RVPH N/A
- PED N/A
- Fundamental
- Price
- RVPH $1.90
- PED $0.87
- Analyst Decision
- RVPH Strong Buy
- PED Strong Buy
- Analyst Count
- RVPH 5
- PED 3
- Target Price
- RVPH $11.40
- PED $1.83
- AVG Volume (30 Days)
- RVPH 3.0M
- PED 165.0K
- Earning Date
- RVPH 11-14-2024
- PED 03-17-2025
- Dividend Yield
- RVPH N/A
- PED N/A
- EPS Growth
- RVPH N/A
- PED 125.69
- EPS
- RVPH N/A
- PED 0.02
- Revenue
- RVPH N/A
- PED $35,719,000.00
- Revenue This Year
- RVPH N/A
- PED $26.32
- Revenue Next Year
- RVPH N/A
- PED $2.77
- P/E Ratio
- RVPH N/A
- PED $34.54
- Revenue Growth
- RVPH N/A
- PED 19.19
- 52 Week Low
- RVPH $0.60
- PED $0.61
- 52 Week High
- RVPH $4.83
- PED $1.10
- Technical
- Relative Strength Index (RSI)
- RVPH 52.37
- PED 52.68
- Support Level
- RVPH $1.56
- PED $0.81
- Resistance Level
- RVPH $2.06
- PED $1.00
- Average True Range (ATR)
- RVPH 0.23
- PED 0.05
- MACD
- RVPH -0.01
- PED 0.00
- Stochastic Oscillator
- RVPH 52.46
- PED 31.93
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on the acquisition and development of oil and natural gas assets in modern drilling and completion techniques and technologies have yet to be applied. The company focuses on legacy proved properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin) and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.